AVEO PHARMACEUTICALS, INC.·4

Feb 17, 5:01 PM ET

Ferraresso Michael 4

4 · AVEO PHARMACEUTICALS, INC. · Filed Feb 17, 2022

Insider Transaction Report

Form 4
Period: 2022-02-15
Ferraresso Michael
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-15+220,000220,000 total
    Exercise: $3.67Exp: 2032-02-15Common Stock (220,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company.

Documents

1 file
  • 4
    wf-form4_164513526016628.xmlPrimary

    FORM 4